Sale by Daniel S. Lorrain (Chief Scientific Officer)
4,170 shares · @ $13.12 · $54,694
Contineum Therapeutics, Inc. Class A Common Stock · PHARMACEUTICAL PREPARATIONS · Now $13.09
+13% in 3d after detection
Post-detection moves
1h
—
1d
+7.2%
3d
+13%
7d
+3.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS